Alamar Biosciences, Inc.

NASDAQ:ALMR

Biotechnology

Healthcare
$30.51 +5.50%

+$1.11 today

Market cap
$2.12B
Beta
0.00
P/E (TTM)
-47.5
EPS (TTM)
-$0.45
52W Low $18.85High $27.20

Volume 0.53M

Average 0.38M

ALMR Sales of Investments

Cash received from selling or redeeming investments.

Alamar Biosciences, Inc.NASDAQ: ALMR

Sales of Investments · Q2 FY2026 · quarter ended Jun 2026

Sales of investments of $0 in Q2 FY2026

Q2 FY2026 sales of investments was $0.

Context

  • Sales of investments amounted to 77.5% of revenue in FY2025.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$0— QoQ
Last fiscal yearDec 2025
$57.5M— YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Sales of Investments history

USD · from the cash flow

Latest · FY2025
57.5M USD
Year-over-year change
—

Sales of Investments vs competitors

How ALMR compares with its peers on the latest reported figures

  • ALMR's FY2025 sales of investments of $57.5M is the 6th largest of the 9 companies compared; the peer median is $122.25M.
  • Sales of investments amounts to 77.5% of revenue for ALMR, versus a peer median of 46.4%.
ALMR Competitors Peer median
Sales of Investments for ALMR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
QSIQuantum-Si incorporatedLTM Mar 2026$396.68M -2.2%+36.6%21418.9%
PACBPacific Biosciences of California, Inc.LTM Mar 2026$274.88M -52.7%-16.1%171.8%
SEERSeer, Inc.LTM Mar 2026$218.45M -26.0%-2.1%1452.6%
TXG10x Genomics, Inc.LTM Jun 2026$125.2M +149.1%+22.8%20.3%
NAUTNautilus Biotechnology, Inc.LTM Mar 2026$119.29M -25.0%-12.6%—
ALMRAlamar Biosciences, Inc.FY2025$57.5M ——77.5%
TWSTTwist Bioscience CorporationLTM Sep 2026$49.35M -1.6%-31.7%10.7%
LABStandard BioTools Inc.LTM Mar 2026$40M -82.5%—46.4%
TECHBio-Techne CorporationLTM Sep 2026$1.99M -66.8%-61.8%0.2%
Peer median (excluding ALMR) $122.25M-25.5%-12.6%46.4%

Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Alamar Biosciences, Inc.

NASDAQ:ALMR

Intrinsic Alpha fair value

Locked

Current Price

$30.51

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.